{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:22:45Z","timestamp":1790076165860,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.iac.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T23:01:40Z","timestamp":1378422100000},"page":"457-470","source":"Crossref","is-referenced-by-count":47,"title":["Hereditary Angioedema with Normal C1 Inhibitor"],"prefix":"10.1016","volume":"33","author":[{"given":"Konrad","family":"Bork","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2013.07.002_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","article-title":"Hereditary angioedema with normal C1-inhibitor activity in women","volume":"356","author":"Bork","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2013.07.002_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1067\/mai.2000.108106","article-title":"Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema","volume":"106","author":"Binkley","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1067\/mai.2001.114242","article-title":"Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission","volume":"107","author":"Martin","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2013.07.002_bib4","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","article-title":"Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel","volume":"33","author":"Zuraw","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2013.07.002_bib5","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","article-title":"Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor","volume":"343","author":"Dewald","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.iac.2013.07.002_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2011.07.002","article-title":"A\u00a0novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor","volume":"141","author":"Bork","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jaci.2009.03.038","article-title":"Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy","volume":"124","author":"Bork","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.amjmed.2007.08.021","article-title":"Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course","volume":"120","author":"Bork","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2013.07.002_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-9343(02)01526-7","article-title":"Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy","volume":"114","author":"Bork","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2013.07.002_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.transci.2003.08.002","article-title":"Estrogen-dependent inherited angioedema","volume":"29","author":"Binkley","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.iac.2013.07.002_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2133.1997.tb14887.x","article-title":"Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema","volume":"136","author":"Sabroe","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2013.07.002_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199818030-00003","article-title":"ACE inhibitor-induced angioedema. Incidence, prevention and management","volume":"18","author":"Vleeming","year":"1998","journal-title":"Drug Saf"},{"key":"10.1016\/j.iac.2013.07.002_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9343(91)80179-P","article-title":"Contraindications to the use of ace inhibitors in patients with C1 esterase inhibitor deficiency","volume":"90","author":"Agostoni","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2013.07.002_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-2133.2005.07048.x","article-title":"Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men","volume":"154","author":"Bork","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2013.07.002_bib15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.amjmed.2003.11.031","article-title":"Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex","volume":"116","author":"Bork","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.iac.2013.07.002_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaci.2007.07.002","article-title":"Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene","volume":"120","author":"Martin","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.anai.2012.05.022","article-title":"Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families","volume":"109","author":"Marcos","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.iac.2013.07.002_bib19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2133.2007.07778.x","article-title":"A\u00a0case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene","volume":"156","author":"Bouillet","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2013.07.002_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/00313020701716433","article-title":"First molecular confirmation of an Australian case of type III hereditary angioedema","volume":"40","author":"Bell","year":"2008","journal-title":"Pathology"},{"key":"10.1016\/j.iac.2013.07.002_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1398-9995.2008.01764.x","article-title":"Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III","volume":"64","author":"Prieto","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2013.07.002_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaci.2008.12.010","article-title":"Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema","volume":"123","author":"Duan","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdermsci.2009.06.013","article-title":"Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema","volume":"56","author":"Nagy","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.iac.2013.07.002_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2008.10.056","article-title":"Angioedema and estrogen-dependent angioedema with activation of the contact system","volume":"123","author":"Hentges","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib25","doi-asserted-by":"crossref","first-page":"957507","DOI":"10.1155\/2010\/957507","article-title":"Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene","volume":"2010","author":"Picone","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.iac.2013.07.002_bib26","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1398-9995.2010.02368.x","article-title":"Type III hereditary angio-oedema: clinical and biological features in a French cohort","volume":"65","author":"Vitrat-Hincky","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2013.07.002_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1398-9995.2011.02562.x","article-title":"Factor XII gene missense mutation Thr328Lys in an Arab family with hereditary angioedema type III","volume":"66","author":"Baeza","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2013.07.002_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0065-2776(08)60599-4","article-title":"The intrinsic coagulation\/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation","volume":"66","author":"Kaplan","year":"1997","journal-title":"Adv Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib29","doi-asserted-by":"crossref","first-page":"13662","DOI":"10.1016\/S0021-9258(19)76478-3","article-title":"Characterization of the human blood coagulation factor XII gene. Intron\/exon gene organization and analysis of the 5'-flanking region","volume":"262","author":"Cool","year":"1987","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2013.07.002_bib30","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.1016\/S0021-9258(17)38776-8","article-title":"Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa","volume":"260","author":"Cool","year":"1985","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iac.2013.07.002_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1432-1033.1992.tb17155.x","article-title":"Control of human coagulation by recombinant serine proteases. Blood clotting is activated by recombinant factor XII deleted of five regulatory domains","volume":"208","author":"Citarella","year":"1992","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.iac.2013.07.002_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1432-1033.1996.0240q.x","article-title":"Structure\/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces","volume":"238","author":"Citarella","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.iac.2013.07.002_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MBC.0b013e32832811f8","article-title":"Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to the factor XII gene mutation Thr309Lys","volume":"20","author":"Bork","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.iac.2013.07.002_bib34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S1081-1206(10)60369-9","article-title":"Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks","volume":"103","author":"Bouillet","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2012.04574.x","article-title":"Safety and efficacy of icatibant self-administration for acute hereditary angioedema","volume":"168","author":"Boccon-Gibod","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.iac.2013.07.002_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1398-9995.2007.01579.x","article-title":"Oestrogen-dependent hereditary angio-oedema with normal C1 inhibitor: description of six new cases and review of pathogenic mechanisms and treatment","volume":"63","author":"Serrano","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2013.07.002_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2133.2004.05669.x","article-title":"Efficacy of danazol treatment in a patient with the new variant of hereditary angio-oedema (HAE III)","volume":"150","author":"Herrmann","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2013.07.002_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.iac.2006.09.003","article-title":"Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations","volume":"26","author":"Bork","year":"2006","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856113000532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856113000532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T16:39:11Z","timestamp":1646498351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856113000532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0889856113000532"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2013.07.002","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}